← Browse by Condition
Medical Condition
metastatic her2 negative breast carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1, Phase 2
NCT05770531 Phase 2
Recruiting
Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy
Enrollment
160 pts
Location
United States
Sponsor
Vanderbilt-Ingram Cancer Cente...
NCT05535413 Phase 1, Phase 2
Recruiting
UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
Enrollment
30 pts
Location
China
Sponsor
Hunan Cancer Hospital